Opus Genetics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $88.8M | $60.0M | $45.1M | $30.8M | $32.4M | $41.8M | $30.3M | $36.6M |
| Accounts Receivable | $1.0M | $1.7M | $2.0M | $2.9M | $3.4M | $3.1M | $3.6M | $1.9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $92.7M | $66.6M | $50.0M | $35.9M | $38.4M | $47.9M | $36.6M | $40.4M |
| Property, Plant & Equipment | $172.0K | $186.0K | $199.0K | $212.0K | $226.0K | $239.0K | $252.0K | $0 |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $93.0M | $66.8M | $50.2M | $36.1M | $38.7M | $48.2M | $36.9M | $40.4M |
| Liabilities | ||||||||
| Accounts Payable | $1.9M | $4.4M | $3.3M | $2.4M | $1.5M | $2.4M | $3.1M | $844.0K |
| Total Current Liabilities | $7.6M | $9.3M | $7.8M | $29.1M | $20.2M | $24.3M | $11.3M | $6.1M |
| Long-Term Debt | $35.3M | $1.2M | $1.1M | $1.1M | $1.0M | — | $0 | — |
| Total Liabilities | $106.0M | $87.9M | $34.9M | $30.2M | $21.2M | $24.3M | $11.3M | $6.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-262.2M | $-254.1M | $-188.6M | $-172.1M | $-154.6M | $-147.2M | $-139.0M | $-103.9M |
| Total Stockholders' Equity | $-13.0M | $-45.8M | $15.3M | $6.0M | $17.5M | $5.1M | $6.7M | $34.3M |